ABNORMALITIES IN MICRORNA EXPRESSION SIGNATURE CAN CONTRIBUTE TO THE GENOME INSTABILITY AND FAILURE OF DNA REPAIR MECHANISMS IN CASE OF DIFFUSE LARGE B-CELL LYMPHOMA

2019 ◽  
Vol 37 ◽  
pp. 347-348
Author(s):  
V. Halytskiy
2014 ◽  
Vol 93 (10) ◽  
pp. 1735-1743 ◽  
Author(s):  
Guoqi Song ◽  
Ling Gu ◽  
Junhong Li ◽  
Zhipeng Tang ◽  
Hong Liu ◽  
...  

Blood ◽  
2011 ◽  
Vol 117 (8) ◽  
pp. 2405-2413 ◽  
Author(s):  
Davide Rossi ◽  
Silvia Rasi ◽  
Alice Di Rocco ◽  
Alberto Fabbri ◽  
Francesco Forconi ◽  
...  

Abstract Several drugs used for diffuse large B-cell lymphoma (DLBCL) treatment rely on DNA damage for tumor cell killing. We verified the prognostic impact of the host DNA repair genotype in 2 independent cohorts of DLBCL treated with R-CHOP21 (training cohort, 163 cases; validation cohort, 145 cases). Among 35 single nucleotide polymorphisms analyzed in the training series, MLH1 rs1799977 was the sole predicting overall survival. DLBCL carrying the MLH1 AG/GG genotype displayed an increased death risk (hazard ratio [HR] = 3.23; P < .001; q =0 .009) compared with patients carrying the AA genotype. Multivariate analysis adjusted for International Prognostic Index identified MLH1 AG/GG as an independent OS predictor (P < .001). The poor prognosis of MLH1 AG/GG was the result of an increased risk of failing both R-CHOP21 (HR = 2.02; P = .007) and platinum-based second-line (HR = 2.26; P = .044) treatment. Survival analysis in the validation series confirmed all outcomes predicted by MLH1 rs1799977. The effect on OS of MLH1, a component of the DNA mismatch repair system, is consistent with its role in regulating the genotoxic effects of doxorubicin and platinum compounds, which are a mainstay of DLBCL first- and second-line treatment.


Oncotarget ◽  
2014 ◽  
Vol 6 (7) ◽  
pp. 4863-4887 ◽  
Author(s):  
Danielle P. Johnson ◽  
Gabriella S. Spitz ◽  
Shweta Tharkar ◽  
Steven N. Quayle ◽  
Jeffrey R. Shearstone ◽  
...  

2007 ◽  
Vol 121 (5) ◽  
pp. 1156-1161 ◽  
Author(s):  
Charles H. Lawrie ◽  
Shamit Soneji ◽  
Teresa Marafioti ◽  
Christopher D.O. Cooper ◽  
Stefano Palazzo ◽  
...  

2019 ◽  
Vol 145 (11) ◽  
pp. 3078-3088 ◽  
Author(s):  
Alanna Maguire ◽  
Xianfeng Chen ◽  
Lee Wisner ◽  
Smriti Malasi ◽  
Colleen Ramsower ◽  
...  

2014 ◽  
Vol 11 (100) ◽  
pp. 20140785 ◽  
Author(s):  
Luz Adriana Nicasio-Collazo ◽  
Alexandra Delgado-González ◽  
Ramón Castañeda-Priego ◽  
Enrique Hernández-Lemus

DNA damage is one of the mechanisms of mutagenesis. Sequence integrity may be affected by the action of thermal changes, chemical agents, both endogenous and exogenous, and other environmental issues. Abnormally high mutation rates are referred to as genomic instability : a phenomenon closely related to the onset of cancer. Mutant genotypes may be able to confer some kind of selective advantage on subclonal cell populations, leading them to multiply until dominance in a localized tissue environment that later becomes the tumour. Cellular stress, especially that of oxidative and ionic nature, is a recognized trigger for DNA-damaging processes. A physico-chemical model has shown that high hysteresis rates in DNA denaturation curves may be indicative of dissipative processes inducing DNA damage, thus potentially leading to uncontrolled mutagenesis and genome instability. We here study selectively to what extent this phenomenon may occur by analysing the sequence length and composition effects on the thermodynamic behaviour and the presence of hysteresis in pressure-driven DNA denaturation; pronounced hysteresis in the denaturation/renaturation curves may indicate thermal susceptibility to DNA damage. In particular, we consider highly mutated regions of the genome characterized in diffuse large B-cell lymphoma on a recent whole exome next-generation sequencing effort.


Sign in / Sign up

Export Citation Format

Share Document